{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:32:06Z","timestamp":1793237526474,"version":"4.5.0"},"reference-count":55,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,22]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Non-Langerhans cell histiocytoses are a diverse group of histiocytic diseases. Different entities are defined based on clinical, histopathologic, and\/or molecular characteristics. This study aimed to define NTRK-rearranged histiocytosis. Through international collaboration, we investigated 50 cases of histiocytosis with pan-tropomyosin receptor kinase (pan-TRK) expression and\/or in-frame NTRK rearrangement. We also analyzed 45 control xanthogranulomas using pan-TRK immunohistochemistry and targeted RNA sequencing. Slides were centrally reviewed; clinical and molecular data were collected. The 50 cases comprised 30 children and 20 adults with a median age of 11.5 years (range, 0-73 years) and a male predominance (64%). Most patients (88%) had disease limited to the skin, including a single skin nodule in 41 patients and multiple skin lesions in 3 others. Four newborns presented with skin lesions, hepatomegaly, and thrombocytopenia that required transfusions. The 2 remaining patients had life-threatening lesions of the brain or bronchus. All cases displayed xanthogranuloma histology, often including foamy histiocytes and Touton giant cells. Histiocytes stained positive for pan-TRK in 50 of 50 cases, whereas all 45 control xanthogranulomas without in-frame NTRK fusions stained negative. NTRK1 fusion partners included IRF2BP2 (23\/46), TPM3 (12\/46), SQSTM1 (3\/46), PRDX1 (3\/46), NPM1 (2\/46), LMNA (2\/46), and ARHGEF2 (1\/46). Clinical outcomes were favorable, including spontaneous disease regression in 3 of 4 newborns with systemic disease, and rapid clinical response in both patients with a brain or bronchial tumor treated with the TRK inhibitor larotrectinib. This study advances the molecular characterization of histiocytoses and may guide the diagnosis and personalized treatment of patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025016167","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T15:14:09Z","timestamp":1746198849000},"page":"3617-3628","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":11,"title":["<i>NTRK1<\/i>\n                    -rearranged histiocytosis: clinicopathologic and molecular features"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7208-9058","authenticated-orcid":false,"given":"Rivers","family":"Fragneau","sequence":"first","affiliation":[{"name":"1Paris-Saclay University, Versailles SQY University, EA4340-BECCOH, Assistance Publique\u2013H\u00f4pitaux de Paris, Ambroise-Par\u00e9 Hospital, Smart Imaging, Service de Pathologie, Boulogne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Fraitag","sequence":"additional","affiliation":[{"name":"2Assistance Publique\u2013H\u00f4pitaux de Paris, Necker Hospital, Service de Pathologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9793-7032","authenticated-orcid":false,"given":"Paul G.","family":"Kemps","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"H\u00e9lias-Rodzewicz","sequence":"additional","affiliation":[{"name":"1Paris-Saclay University, Versailles SQY University, EA4340-BECCOH, Assistance Publique\u2013H\u00f4pitaux de Paris, Ambroise-Par\u00e9 Hospital, Smart Imaging, Service de Pathologie, Boulogne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5681-0112","authenticated-orcid":false,"given":"Somak","family":"Roy","sequence":"additional","affiliation":[{"name":"4Division of Pathology, Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bonsang","sequence":"additional","affiliation":[{"name":"1Paris-Saclay University, Versailles SQY University, EA4340-BECCOH, Assistance Publique\u2013H\u00f4pitaux de Paris, Ambroise-Par\u00e9 Hospital, Smart Imaging, Service de Pathologie, Boulogne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison L.","family":"Bartlett","sequence":"additional","affiliation":[{"name":"5Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhra","family":"Dhar","sequence":"additional","affiliation":[{"name":"6Department of Dermatopathology, Wizderm Clinics, Kolkata, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4541-9820","authenticated-orcid":false,"given":"Martin","family":"Jankofsky","sequence":"additional","affiliation":[{"name":"7Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Zlocha","sequence":"additional","affiliation":[{"name":"8Department of Pediatrics, Clinic Chemnitz, Chemnitz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1267-4072","authenticated-orcid":false,"given":"Karel","family":"Svojgr","sequence":"additional","affiliation":[{"name":"9Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6113-6310","authenticated-orcid":false,"given":"Lenka","family":"Krskov\u00e1","sequence":"additional","affiliation":[{"name":"9Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic"},{"name":"10Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrica C. H.","family":"de Vries","sequence":"additional","affiliation":[{"name":"11Sophia Children\u2019s Hospital, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1437-214X","authenticated-orcid":false,"given":"Robert M.","family":"Verdijk","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"12Department of Pathology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8885-4929","authenticated-orcid":false,"given":"Jan A. M.","family":"van Laar","sequence":"additional","affiliation":[{"name":"13Department of Internal Medicine, Section Clinical Immunology and Allergology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands"},{"name":"14Department of Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roos J.","family":"Leguit","sequence":"additional","affiliation":[{"name":"15Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0273-0050","authenticated-orcid":false,"given":"Philippe","family":"Drabent","sequence":"additional","affiliation":[{"name":"2Assistance Publique\u2013H\u00f4pitaux de Paris, Necker Hospital, Service de Pathologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Carlsen","sequence":"additional","affiliation":[{"name":"16Department of Pathology, Duke University Medical Center, Durham, NC"},{"name":"17Department of Pathology, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonhan","family":"Ho","sequence":"additional","affiliation":[{"name":"18Department of Dermatology, University of Pittsburgh School of Medicine, UPMC, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arivarasan D.","family":"Karunamurthy","sequence":"additional","affiliation":[{"name":"18Department of Dermatology, University of Pittsburgh School of Medicine, UPMC, Pittsburgh, PA"},{"name":"19Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarita","family":"Santi","sequence":"additional","affiliation":[{"name":"20Department of Pathology and Laboratory Medicine, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Julli\u00e9","sequence":"additional","affiliation":[{"name":"21Department of Pathology, University Hospital of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Babor","sequence":"additional","affiliation":[{"name":"22Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Center of Child and Adolescent Health, Heinrich-Heine-University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lorsbach","sequence":"additional","affiliation":[{"name":"4Division of Pathology, Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0563-4155","authenticated-orcid":false,"given":"Astrid G. S.","family":"van Halteren","sequence":"additional","affiliation":[{"name":"13Department of Internal Medicine, Section Clinical Immunology and Allergology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"H\u00e9ritier","sequence":"additional","affiliation":[{"name":"23French Reference Center for Histiocytosis, Department of Pediatric Hematology and Oncology, Trousseau Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris, Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5456-5961","authenticated-orcid":false,"given":"Eli L.","family":"Diamond","sequence":"additional","affiliation":[{"name":"24Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8090-5448","authenticated-orcid":false,"given":"Benjamin H.","family":"Durham","sequence":"additional","affiliation":[{"name":"25Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8306-8419","authenticated-orcid":false,"given":"Ashish R.","family":"Kumar","sequence":"additional","affiliation":[{"name":"5Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5709-4456","authenticated-orcid":false,"given":"Arunaloke","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"26Department of Pediatrics, Institute of Child Health, Kolkata, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Haroche","sequence":"additional","affiliation":[{"name":"27Sorbonne University, Internal Medicine Department 2, Institut E3M, French Reference Centre for Histiocytosis, Piti\u00e9-Salp\u0207tri\u00e8re Hospital, CIMI INSERM-UMRS 1135, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4485-146X","authenticated-orcid":false,"given":"Jean","family":"Donadieu","sequence":"additional","affiliation":[{"name":"23French Reference Center for Histiocytosis, Department of Pediatric Hematology and Oncology, Trousseau Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris, Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6121-4737","authenticated-orcid":false,"given":"Arndt","family":"Borkhardt","sequence":"additional","affiliation":[{"name":"22Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Center of Child and Adolescent Health, Heinrich-Heine-University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3718-6422","authenticated-orcid":false,"given":"Jennifer L.","family":"Picarsic","sequence":"additional","affiliation":[{"name":"4Division of Pathology, Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH"},{"name":"19Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA"},{"name":"28Department of Pathology, UPMC Children\u2019s Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6073-4466","authenticated-orcid":false,"given":"Jean-Fran\u00e7ois","family":"Emile","sequence":"additional","affiliation":[{"name":"1Paris-Saclay University, Versailles SQY University, EA4340-BECCOH, Assistance Publique\u2013H\u00f4pitaux de Paris, Ambroise-Par\u00e9 Hospital, Smart Imaging, Service de Pathologie, Boulogne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"issue":"22","key":"2025072209263814300_bib1","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","article-title":"Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages","volume":"127","author":"Emile","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2025072209263814300_bib2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/his.15127","article-title":"Demographics and additional haematologic cancers of patients with histiocytic\/dendritic cell neoplasms","volume":"84","author":"Kemps","year":"2024","journal-title":"Histopathology"},{"issue":"4","key":"2025072209263814300_bib3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/pde.14174","article-title":"Juvenile xanthogranulomas: examining single, multiple, and extracutaneous presentations","volume":"37","author":"So","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"2025072209263814300_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1468-3083.2010.03819.x","article-title":"Structural correlations between dermoscopic and histopathological features of juvenile xanthogranuloma","volume":"25","author":"Song","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"2025072209263814300_bib5","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1159\/000510265","article-title":"Dermoscopy of juvenile xanthogranuloma","volume":"237","author":"Peruilh-Bagolini","year":"2021","journal-title":"Dermatology"},{"issue":"23","key":"2025072209263814300_bib6","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1182\/blood.2024025127","article-title":"Recurrent CLTC::SYK fusions and CSF1R mutations in juvenile xanthogranuloma of soft tissue","volume":"144","author":"Kemps","year":"2024","journal-title":"Blood"},{"issue":"5","key":"2025072209263814300_bib7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000478-200305000-00003","article-title":"Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations","volume":"27","author":"Dehner","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2025072209263814300_bib8","doi-asserted-by":"crossref","first-page":"e30232","DOI":"10.1002\/pbc.30232","article-title":"Systemic juvenile xanthogranuloma: a systematic review","volume":"70","author":"Zou","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"2025072209263814300_bib9","doi-asserted-by":"crossref","first-page":"e28381","DOI":"10.1002\/pbc.28381","article-title":"Long-term outcomes of children with extracutaneous juvenile xanthogranulomas in Japan","volume":"67","author":"Maeda","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2025072209263814300_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/his.14569","article-title":"Cutaneous histiocytosis in children","volume":"80","author":"Fraitag","year":"2022","journal-title":"Histopathology"},{"issue":"1","key":"2025072209263814300_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41572-021-00307-9","article-title":"Histiocytic disorders","volume":"7","author":"McClain","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2025072209263814300_bib12","first-page":"242","volume-title":"Haematolymphoid tumours","author":"Alaggio","year":"2024","edition":"5th"},{"issue":"11","key":"2025072209263814300_bib13","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"issue":"13","key":"2025072209263814300_bib14","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","article-title":"High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses","volume":"120","author":"Haroche","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2025072209263814300_bib15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","article-title":"Diverse and targetable kinase alterations drive histiocytic neoplasms","volume":"6","author":"Diamond","year":"2016","journal-title":"Cancer Discov"},{"issue":"12","key":"2025072209263814300_bib16","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41591-019-0653-6","article-title":"Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms","volume":"25","author":"Durham","year":"2019","journal-title":"Nat Med"},{"issue":"25","key":"2025072209263814300_bib17","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1200\/JCO.2015.65.9508","article-title":"BRAF mutation correlates with high-risk Langerhans cell histiocytosis and increased resistance to first-line therapy","volume":"34","author":"H\u00e9ritier","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4","key":"2025072209263814300_bib18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/bloodadvances.2022007947","article-title":"Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study","volume":"7","author":"Kemps","year":"2023","journal-title":"Blood Adv"},{"key":"2025072209263814300_bib19","doi-asserted-by":"crossref","first-page":"104320","DOI":"10.1016\/j.yexmp.2019.104320","article-title":"BRAF V600E mutations are not an oncogenic driver of solitary xanthogranuloma and reticulohistiocytoma: testing may be useful in screening for Erdheim-Chester disease","volume":"111","author":"Hoyt","year":"2019","journal-title":"Exp Mol Pathol"},{"issue":"23","key":"2025072209263814300_bib20","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.1182\/bloodadvances.2023011414","article-title":"Histiocytic neoplasm subtypes differ in their MAP2K1 mutational type","volume":"7","author":"Emile","year":"2023","journal-title":"Blood Adv"},{"issue":"3","key":"2025072209263814300_bib21","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamaoncol.2017.5029","article-title":"Vemurafenib for BRAF V600-Mutant Erdheim-Chester disease and Langerhans cell histiocytosis: analysis of data from the histology-independent, phase 2, open-label VE-BASKET study","volume":"4","author":"Diamond","year":"2018","journal-title":"JAMA Oncol"},{"issue":"31","key":"2025072209263814300_bib22","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1200\/JCO.19.00456","article-title":"Vemurafenib for refractory multisystem Langerhans cell histiocytosis in children: an international observational study","volume":"37","author":"Donadieu","year":"2019","journal-title":"J Clin Oncol"},{"issue":"7749","key":"2025072209263814300_bib23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41586-019-1012-y","article-title":"Efficacy of MEK inhibition in patients with histiocytic neoplasms","volume":"567","author":"Diamond","year":"2019","journal-title":"Nature"},{"issue":"2","key":"2025072209263814300_bib24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.2021013338","article-title":"ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition","volume":"139","author":"Kemps","year":"2022","journal-title":"Blood"},{"issue":"2","key":"2025072209263814300_bib25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bjd\/ljad427","article-title":"Disseminated juvenile xanthogranulomas with underlying neurotrophic tyrosine receptor kinase fusion and response to larotrectinib","volume":"190","author":"Kim","year":"2024","journal-title":"Br J Dermatol"},{"issue":"8","key":"2025072209263814300_bib26","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"2025072209263814300_bib27","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1172\/JCI120787","article-title":"Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies","volume":"128","author":"Taylor","year":"2018","journal-title":"J Clin Invest"},{"issue":"11","key":"2025072209263814300_bib28","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jdcr.2020.05.032","article-title":"Disseminated non-Langerhans cell histiocytosis with an IRF2BP2-NTRK1 gene fusion identified by next-generation sequencing","volume":"6","author":"Chan","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"2","key":"2025072209263814300_bib29","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41379-020-00657-x","article-title":"Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions","volume":"34","author":"Br\u010di\u0107","year":"2021","journal-title":"Mod Pathol"},{"key":"2025072209263814300_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.pathol.2023.11.014","article-title":"Epithelioid cell histiocytoma associated with IRF2BP2::NTRK1 fusion","author":"Wood","year":"2024","journal-title":"Pathology"},{"issue":"8","key":"2025072209263814300_bib31","doi-asserted-by":"crossref","first-page":"13030\/qt07d3f2xk","DOI":"10.5070\/D3228032091","article-title":"Generalized eruptive histiocytosis associated with a novel fusion in LMNA-NTRK1","volume":"22","author":"Pinney","year":"2016","journal-title":"Dermatol Online J"},{"issue":"9","key":"2025072209263814300_bib32","first-page":"1231","article-title":"Adult xanthogranuloma with LMNA-NTRK1 gene fusion - a possible driver of proliferation","volume":"20","author":"Ak","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"issue":"5","key":"2025072209263814300_bib33","first-page":"1624","article-title":"B-cell acute lymphoblastic leukemia and juvenile xanthogranuloma in a patient with ETV6 thrombocytopenia and leukemia predisposition syndrome: novel clinical presentation and perspective","volume":"109","author":"Newman","year":"2024","journal-title":"Haematologica"},{"issue":"11","key":"2025072209263814300_bib34","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/cup.14510","article-title":"NTRK expression is common in xanthogranuloma and is associated with the solitary variant","volume":"50","author":"Umphress","year":"2023","journal-title":"J Cutan Pathol"},{"issue":"1","key":"2025072209263814300_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ijc.31636","article-title":"A novel fusion gene PLEKHA6-NTRK3 in langerhans cell histiocytosis","volume":"144","author":"Cai","year":"2019","journal-title":"Int J Cancer"},{"issue":"10295","key":"2025072209263814300_bib36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(21)00311-1","article-title":"Histiocytosis","volume":"398","author":"Emile","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"2025072209263814300_bib37","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.3324\/haematol.2019.216937","article-title":"Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by MAP2K1","volume":"105","author":"Razanamahery","year":"2020","journal-title":"Haematologica"},{"issue":"9","key":"2025072209263814300_bib38","first-page":"3048","article-title":"Clinical phenotype of adult-onset systemic histiocytosis harboring BRAF in-frame deletions","volume":"109","author":"Papo","year":"2024","journal-title":"Haematologica"},{"issue":"1","key":"2025072209263814300_bib39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/dermatopathology11010010","article-title":"Kinase fusions in spitz melanocytic tumors: the past, the present, and the future","volume":"11","author":"Daruish","year":"2024","journal-title":"Dermatopathology (Basel)"},{"issue":"7","key":"2025072209263814300_bib40","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1182\/blood-2008-03-147017","article-title":"ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy","volume":"112","author":"Chan","year":"2008","journal-title":"Blood"},{"issue":"11","key":"2025072209263814300_bib41","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood-2017-03-771873","article-title":"Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study)","volume":"130","author":"Cohen Aubart","year":"2017","journal-title":"Blood"},{"issue":"3","key":"2025072209263814300_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bneo.2024.100023","article-title":"Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium","volume":"1","author":"Kemps","year":"2024","journal-title":"Blood Neoplasia"},{"issue":"22","key":"2025072209263814300_bib43","doi-asserted-by":"crossref","first-page":"5796","DOI":"10.1182\/bloodadvances.2024013545","article-title":"Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms","volume":"8","author":"Ozkaya","year":"2024","journal-title":"Blood Adv"},{"issue":"5","key":"2025072209263814300_bib44","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ajh.27263","article-title":"Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis","volume":"99","author":"Ruan","year":"2024","journal-title":"Am J Hematol"},{"issue":"8","key":"2025072209263814300_bib45","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1182\/blood-2017-01-761718","article-title":"High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis","volume":"130","author":"Papo","year":"2017","journal-title":"Blood"},{"issue":"18","key":"2025072209263814300_bib46","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood.2023021212","article-title":"BRAFV600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis","volume":"142","author":"Acosta-Medina","year":"2023","journal-title":"Blood"},{"issue":"3","key":"2025072209263814300_bib47","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1182\/bloodadvances.2024013696","article-title":"Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosis","volume":"9","author":"Kemps","year":"2025","journal-title":"Blood Adv"},{"issue":"3","key":"2025072209263814300_bib48","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2350\/09-03-0622-OA.1","article-title":"Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature","volume":"13","author":"Castro","year":"2012 2010","journal-title":"Pediatr Dev Pathol"},{"issue":"2","key":"2025072209263814300_bib49","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00000372-200104000-00004","article-title":"\u201cJuvenile\u201d xanthogranuloma: an immunophenotypic study with a reappraisal of histogenesis","volume":"23","author":"Kraus","year":"2001","journal-title":"Am J Dermatopathol"},{"issue":"9","key":"2025072209263814300_bib50","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/annonc\/mdz204","article-title":"ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research","volume":"30","author":"Marchi\u00f2","year":"2019","journal-title":"Ann Oncol"},{"issue":"1","key":"2025072209263814300_bib51","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13000-023-01426-5","article-title":"Validation and interpretation of pan-TRK immunohistochemistry: a practical approach and challenges with interpretation","volume":"19","author":"Karakas","year":"2024","journal-title":"Diagn Pathol"},{"issue":"1","key":"2025072209263814300_bib52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41698-021-00206-y","article-title":"Genomic context of NTRK1\/2\/3 fusion-positive tumours from a large real-world population","volume":"5","author":"Westphalen","year":"2021","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"2025072209263814300_bib53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41698-023-00449-x","article-title":"ALK fusions in the pan-cancer setting: another tumor-agnostic target?","volume":"7","author":"Shreenivas","year":"2023","journal-title":"NPJ Precis Oncol"},{"issue":"20","key":"2025072209263814300_bib54","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1182\/blood-2015-07-655530","article-title":"ETV3-NCOA2 in indeterminate cell histiocytosis: clonal translocation supports sui generis","volume":"126","author":"Brown","year":"2015","journal-title":"Blood"},{"issue":"10","key":"2025072209263814300_bib55","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/PAS.0000000000002102","article-title":"Expanding our knowledge of molecular pathogenesis in histiocytoses: solitary soft tissue histiocytomas in children with a novel CLTC::SYK fusion","volume":"47","author":"Crowley","year":"2023","journal-title":"Am J Surg Pathol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/14\/3617\/2402769\/blooda_adv-2025-016167-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/14\/3617\/2402769\/blooda_adv-2025-016167-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T13:26:50Z","timestamp":1753190810000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/14\/3617\/537101\/NTRK1-rearranged-histiocytosis-clinicopathologic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":55,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,7,22]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016167","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7,22]]},"published":{"date-parts":[[2025,7,14]]}}}